Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
148
Millions of yenWording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPNet Sales990Millions of yenYear on year -0.3%Progress 48.3%
Operating profit111Millions of yenProgress 55.5%
Ordinary income109Millions of yenProgress 54.5%
Net income attributable to owners of the parent84Millions of yenProgress 40.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥8.27
Financial position at period-end
Total assets8,886Millions of yen
of which net assets 8,228 Millions of yenEquity ratio 90.7%vs. prior year-end +0.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueHealthcare-related 925 Millions of yen (YoY -0.4%), Real estate-related operations 64 Millions of yen (YoY +0.7%)
Segment profitHealthcare-related 314 Millions of yen (YoY +106.4%), Real estate-related operations 22 Millions of yen (YoY +1.7%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales2,051 Millions of yen (YoY +35.2%)
Operating profit200 Millions of yen
Ordinary income200 Millions of yen
Net income206 Millions of yen
Revision to Earnings ForecastNet Sales Not disclosed → 2,051 Millions of yen / Operating profit Not disclosed → 200 Millions of yen / Ordinary income Not disclosed → 200 Millions of yen / Net income Not disclosed → 206 Millions of yen
Annual Dividend Forecast0 Yen → 3 Yen
Factors Behind Changes in Business Performance
The number of employees declined from 95 to 55, reducing personnel expenses by ¥76 million. In the medical tourism business, progress in business operations and cost reductions resulted in a return to profitability on a basis excluding head office administrative expenses.
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 None見積りの変更 None修正再表示 None
Changes in the scope of consolidationNew 1 / Name of newly included company グローム・エナジー株式会社 / Excluded 0 / Excluded Company Name Not disclosed
Impairment lossNo applicable matters
Breakdown of extraordinary income (loss)Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of fixed assets 0 Millions of yen, Total extraordinary losses 0 Millions of yen
Depreciation and amortization34 Millions of yen
Availability of Supplementary Financial Results MaterialsNone
Availability of Financial Results BriefingWhether applicable None / Subject person Not disclosed
Issued Shares at Period-End11,293,500
Treasury Shares at Period-End639
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | 990 Millions of yen (YoY -0.3%) |
| Operating profit | 111 Millions of yen |
| Ordinary income | 109 Millions of yen |
| Profit attributable to owners of the parent | 84 Millions of yen |
| Net income per share | ¥8.27 |
| Equity ratio | End of the current fiscal period 90.7 / End of previous period 90.3 |
| Total assets | 8,886 Millions of yen |
| Net assets | 8,228 Millions of yen |
| Full-year earnings forecast | Net Sales 2,051 Millions of yen (YoY +35.2%) / Operating profit 200 Millions of yen / Ordinary income 200 Millions of yen / Net income 206 Millions of yen |
| Revision to Earnings Forecast | Net Sales Not disclosed → 2,051 Millions of yen / Operating profit Not disclosed → 200 Millions of yen / Ordinary income Not disclosed → 200 Millions of yen / Net income Not disclosed → 206 Millions of yen |
| Annual Dividend Forecast | 0 Yen → 3 Yen |
| Segment revenue | Healthcare-related 925 Millions of yen (YoY -0.4%), Real estate-related operations 64 Millions of yen (YoY +0.7%) |
| Segment profit | Healthcare-related 314 Millions of yen (YoY +106.4%), Real estate-related operations 22 Millions of yen (YoY +1.7%) |
| Depreciation and amortization | 34 Millions of yen |
| Impairment loss | No applicable matters |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on disposal of fixed assets 0 Millions of yen, Total extraordinary losses 0 Millions of yen |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement None |
| Changes in the scope of consolidation | New 1 / Name of newly included company グローム・エナジー株式会社 / Excluded 0 / Excluded Company Name Not disclosed |
| Availability of Supplementary Financial Results Materials | None |
| Availability of Financial Results Briefing | Whether applicable None / Subject person Not disclosed |
| Issued Shares at Period-End | 11,293,500 |
| Treasury Shares at Period-End | 639 |
| Factors Behind Changes in Business Performance | The number of employees declined from 95 to 55, reducing personnel expenses by ¥76 million. In the medical tourism business, progress in business operations and cost reductions resulted in a return to profitability on a basis excluding head office administrative expenses. |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Personnel expenses decreased by ¥76 million, mainly due to a decline in the number of employees. In addition, progress in business operations and cost reductions in the medical tourism business resulted in a return to profitability.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.